Neonatal Outcome Clinical Trial
Official title:
Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section: A Randomized, Double Blind Clinical Trial
This prospective double-blind placebo-controlled randomized clinical trial will be conducted
at Ain-Shams University Maternity Hospital from April 2017 till December 2017. Group 1 women,
candidates for cesarean section, will receive preoperative rectal 400 microgram of
misoprostol, and Group 2 women will receive postoperative rectal 400 microgram of
misoprostol.
2017. 120 women candidate foe elective cesarean section will receive preoperative sublingual
400 microgram of misoprostol, and another 120 women will receive postoperative sublingual 400
microgram of misoprostol.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01261689 -
The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT)
|
N/A | |
| Completed |
NCT03451864 -
Maternal 25-hydroxy Vitamin D Level and Adverse Outcomes in Near Term and Full Term Neonates
|
N/A | |
| Recruiting |
NCT04766866 -
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
|
N/A | |
| Completed |
NCT03008577 -
Hypothermia and the Effect of Ambient Temperature 2
|
N/A | |
| Completed |
NCT00580268 -
Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity
|
N/A |